Some patients on GLP-1 medications report mood changes, including anxiety and depressive symptoms
focused on the development and commercialization of novel immuno-oncology therapies, Agenus will receive $150 million upfront including $30 million equity investment, and the agreement also includes approximately $1.7 billion in potential milestones
Our clinical team looks at the whole picture: your labs, hormones, body composition, sleep, and goals
Semaglutide is an FDA-approved medication that mimics the action of the GLP-1 hormone, which regulates appetite and food intake
Tirzepatide while breastfeeding: what the newer data shows Tirzepatide has less published data than semaglutide but the existing evidence points in the same direction
This does not mean every detail is fully proven in humans